332 related articles for article (PubMed ID: 12635090)
41. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides.
Gudermann T; Roelle S
Endocr Relat Cancer; 2006 Dec; 13(4):1069-84. PubMed ID: 17158754
[TBL] [Abstract][Full Text] [Related]
42. Galectin-3: differential expression between small-cell and non-small-cell lung cancer.
Buttery R; Monaghan H; Salter DM; Sethi T
Histopathology; 2004 Apr; 44(4):339-44. PubMed ID: 15049899
[TBL] [Abstract][Full Text] [Related]
43. [Oncogenes--"reckless drivers" on signal pathways controlling cell division].
Johansen T; Bjørkøy G
Tidsskr Nor Laegeforen; 1998 May; 118(12):1880-5. PubMed ID: 9638058
[TBL] [Abstract][Full Text] [Related]
44. Molecular abnormalities in lung cancer.
Salgia R; Skarin AT
J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
[TBL] [Abstract][Full Text] [Related]
45. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of L985P, a CD20 related family member over-expressed in small cell lung carcinoma.
Bangur CS; Johnson JC; Switzer A; Wang YH; Hill B; Fanger GR; Wang T; Retter MW
Int J Oncol; 2004 Dec; 25(6):1583-90. PubMed ID: 15547694
[TBL] [Abstract][Full Text] [Related]
47. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.
Taniwaki M; Daigo Y; Ishikawa N; Takano A; Tsunoda T; Yasui W; Inai K; Kohno N; Nakamura Y
Int J Oncol; 2006 Sep; 29(3):567-75. PubMed ID: 16865272
[TBL] [Abstract][Full Text] [Related]
48. [Molecular cancer biology--from research to clinical practice].
Nielsen FC
Ugeskr Laeger; 2003 Feb; 165(9):897-900. PubMed ID: 12661511
[TBL] [Abstract][Full Text] [Related]
49. [Cancer genetics. A review of oncological molecular biology seen in relation to the human genome].
Gerdes AM
Ugeskr Laeger; 2002 May; 164(22):2865-71. PubMed ID: 12082811
[TBL] [Abstract][Full Text] [Related]
50. Biology and novel therapeutics for neuroendocrine tumors of the lung.
Jafri N; Salgia R
J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694
[TBL] [Abstract][Full Text] [Related]
51. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of KIT expression in small cell lung cancer.
López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
[TBL] [Abstract][Full Text] [Related]
53. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
54. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
[TBL] [Abstract][Full Text] [Related]
55. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation.
Morinaga R; Okamoto I; Furuta K; Kawano Y; Sekijima M; Dote K; Satou T; Nishio K; Fukuoka M; Nakagawa K
Lung Cancer; 2007 Dec; 58(3):411-3. PubMed ID: 17601631
[TBL] [Abstract][Full Text] [Related]
56. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
57. The molecular effects of oncogenesis on cell-extracellular matrix adhesion (review).
Nadav L; Katz BZ
Int J Oncol; 2001 Aug; 19(2):237-46. PubMed ID: 11445834
[TBL] [Abstract][Full Text] [Related]
58. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
[TBL] [Abstract][Full Text] [Related]
59. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
60. Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy.
Furukawa K; Hamamura K; Aixinjueluo W; Furukawa K
Ann N Y Acad Sci; 2006 Nov; 1086():185-98. PubMed ID: 17185516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
